Heidi Cuthbert

Werewolf Therapeutics (NASDAQ:HOWL) and Ambros Therapeutics entered an all-stock merger agreement that will create a Nasdaq-listed biotechnology company focused on developing neridronate for Complex Regional Pain Syndrome Type 1 (CRPS-1).

Ubiquiti (NYSE:UI) reported fiscal 2026 revenue of $3.3 billion and GAAP diluted earnings per share of $15.85 for the year ended June 30, 2026.

PermRock Royalty Trust (NYSE:PRT) declared a monthly cash distribution of $265,001.53, or $0.021782 per Trust Unit, based mainly on June 2026 production.

Lifestyle Communities (ASX:LIC) delivered a statutory profit after tax of $46.9 million for the financial year ended June 30.

Charter Hall Group (ASX:CHC) announced operating earnings of $488.1 million for the 2026 financial year.

Peter Warren Automotive (ASX:PWR) reported an underlying profit before tax of $14.5 million for FY26.

Sol-Gel (NASDAQ:SLGL) reported second quarter 2026 revenue of $0.6 million, down from $17.3 million a year earlier due mainly to a prior-year $16.7 million intellectual property sale to Mayne.

Twin Disc (NASDAQ:TWIN) reported fiscal 2026 net sales of $381.3 million, up 11.9% year-over-year, while net income attributable to the company increased to $27.1 million compared with a loss in the prior year.

Advance Auto Parts (NYSE:AAP) reported second quarter 2026 net sales of $2 billion, while operating income increased to $101 million from $22 million a year earlier as margins improved.

Huize Holding (NASDAQ:HUIZ) reported first half 2026 gross written premiums of RMB4,196.4 million, up 29.8% year-over-year, while revenue increased 5.8% to RMB719.8 million and profitability improved.